Elanco CFO granted 8.15 deferred stock units

VanHimbergen Robert M reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

VanHimbergen Robert M reported acquisition or exercise transactions in this Form 4 filing.

Elanco Animal Health EVP and CFO Robert M. VanHimbergen received a grant of 8.1514 deferred stock units of Elanco common stock at a reference price of $24.17 per unit. Following this grant, he holds 100.8319 deferred stock units directly.

Each deferred stock unit represents the right to receive one share of Elanco common stock or the cash equivalent. These units settle in cash or shares after employment ends or in a specified future year under the company’s Executive Deferral and Stock Match Plan.

Insider Trade Summary

Grant/Award: 8.1514 shares

Grant/Award 1 txn

Insider VanHimbergen Robert M

Role EVP and CFO

Type	Security	Shares	Price	Value
Grant/Award	Deferred Stock Units	8.1514	$24.17	$197.02

Holdings After Transaction: Deferred Stock Units — 100.8319 contracts (Direct)

Footnotes (2)

1. F1. Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent.
2. F2. Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan.

Key Figures

Deferred stock units granted: 8.1514 units Reference price per unit: $24.17 per unit Deferred stock units after grant: 100.8319 units +2 more

5 metrics

Deferred stock units granted 8.1514 units Grant of deferred stock units on 2026-06-12

Reference price per unit $24.17 per unit Valuation reference for deferred stock unit grant

Deferred stock units after grant 100.8319 units Total deferred stock units held directly after transaction

Underlying security shares 8.1514 shares Each unit corresponds to one share of common stock

Transaction code A (Grant, award, or other acquisition) Indicates compensation-related acquisition on Form 4

Key Terms

Deferred Stock Units, Executive Deferral and Stock Match Plan, derivative

3 terms

Deferred Stock Units financial

"Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent."

Deferred stock units are promises from a company to give an employee shares of stock at a future date, often after certain conditions are met or after leaving the company. They function like a form of delayed compensation, allowing employees to earn shares over time. For investors, they represent potential future ownership in the company, but do not provide immediate voting rights or dividends until the shares are actually received.

Executive Deferral and Stock Match Plan financial

"Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan."

derivative financial

"The transaction is classified as a derivative transaction involving deferred stock units."

A derivative is a financial contract whose value depends on the price or performance of another asset or measure — for example a stock, index, interest rate, commodity, or currency. Investors use derivatives like insurance or leveraged bets to hedge risk, speculate, or gain exposure without owning the underlying asset; they can protect portfolios but also amplify losses and introduce counterparty and market risk.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Elanco (ELAN) EVP and CFO VanHimbergen report on this Form 4?

Elanco EVP and CFO Robert M. VanHimbergen reported receiving 8.1514 deferred stock units. These units represent a right to future Elanco common stock or cash, reflecting routine executive compensation rather than an open-market stock purchase or sale.

How many deferred stock units does the Elanco (ELAN) CFO hold after this transaction?

After this grant, the Elanco CFO holds 100.8319 deferred stock units directly. These units track Elanco common stock value and will be settled in cash or shares after employment ends or in a specified future year, according to the company’s executive deferral plan.

Is the Elanco (ELAN) Form 4 transaction a market buy or sell of shares?

The Form 4 shows a compensation-related grant, not a market buy or sell. Robert M. VanHimbergen acquired 8.1514 deferred stock units through a grant, classified as a derivative award rather than an open-market stock transaction involving immediate cash outlay or proceeds.

What does each Elanco (ELAN) deferred stock unit represent for the CFO?

Each deferred stock unit represents the right to receive one Elanco common share or its cash equivalent. This means the CFO’s 100.8319 units give future entitlement linked to the company’s stock value, subject to settlement terms defined in the Executive Deferral and Stock Match Plan.

When will the Elanco (ELAN) CFO’s deferred stock units be settled?

The deferred stock units will be settled in cash or Elanco common stock after employment termination or in a specified future year. Settlement timing follows the rules of Elanco’s Executive Deferral and Stock Match Plan, which governs when and how these compensation awards are paid.

What price is associated with the Elanco (ELAN) deferred stock unit grant?

The deferred stock unit grant is associated with a reference price of $24.17 per unit. While the grant itself does not involve an immediate cash purchase, this price is used to value the award under the company’s executive compensation and deferral arrangements.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/16/2026 - 04:33 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

VanHimbergen Robert M

(Last) (First) (Middle)

C/O ELANCO ANIMAL HEALTH INCORPORATED

450 ELANCO CIRCLE

(Street)

INDIANAPOLIS INDIANA 46221

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Elanco Animal Health Inc [ ELAN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP and CFO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/12/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Deferred Stock Units	(1)	06/12/2026		A		8.1514		(2)	(2)	Common Stock	8.1514	$24.17	100.8319	D

Explanation of Responses:

1. Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent.

2. Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan.

	/s/ Amy C. Seidel, as Attorney-in-Fact for Robert M. VanHimbergen	06/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)